Swiss National Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $507M | Buy |
3,641,000
+240,800
| +7% | +$33.7M | 0.29% | 53 |
|
|
2025
Q4 | $417M | Sell |
3,400,200
-185,400
| -5% | -$22.5M | 0.25% | 66 |
|
|
2025
Q3 | $398M | Sell |
3,585,600
-188,100
| -5% | -$21.4M | 0.23% | 73 |
|
|
2025
Q2 | $418M | Buy |
3,773,700
+258,700
| +7% | +$27.5M | 0.25% | 63 |
|
|
2025
Q1 | $394M | Sell |
3,515,000
-2,000
| -0.1% | -$206K | 0.28% | 59 |
|
|
2024
Q4 | $325M | Sell |
3,517,000
-180,900
| -5% | -$16.3M | 0.22% | 75 |
|
|
2024
Q3 | $310M | Buy |
3,697,900
+5,900
| +0.2% | +$450K | 0.2% | 87 |
|
|
2024
Q2 | $253M | Sell |
3,692,000
-39,500
| -1% | -$2.64M | 0.17% | 97 |
|
|
2024
Q1 | $273M | Sell |
3,731,500
-164,800
| -4% | -$12.7M | 0.19% | 93 |
|
|
2023
Q4 | $316M | Sell |
3,896,300
-115,900
| -3% | -$9.02M | 0.23% | 78 |
|
|
2023
Q3 | $301M | Sell |
4,012,200
-498,000
| -11% | -$38.3M | 0.24% | 76 |
|
|
2023
Q2 | $348M | Sell |
4,510,200
-467,300
| -9% | -$37.3M | 0.24% | 76 |
|
|
2023
Q1 | $413M | Sell |
4,977,500
-116,500
| -2% | -$9.65M | 0.28% | 67 |
|
|
2022
Q4 | $437M | Sell |
5,094,000
-341,898
| -6% | -$27.1M | 0.31% | 61 |
|
|
2022
Q3 | $335M | Sell |
5,435,898
-3,300
| -0.1% | -$208K | 0.24% | 72 |
|
|
2022
Q2 | $336M | Buy |
5,439,198
+6,100
| +0.1% | +$378K | 0.23% | 77 |
|
|
2022
Q1 | $323M | Buy |
5,433,098
+667,400
| +14% | +$42.7M | 0.18% | 97 |
|
|
2021
Q4 | $346M | Sell |
4,765,698
-193,400
| -4% | -$13.3M | 0.21% | 83 |
|
|
2021
Q3 | $346M | Sell |
4,959,098
-164,800
| -3% | -$11.6M | 0.22% | 82 |
|
|
2021
Q2 | $353M | Sell |
5,123,898
-1,268,325
| -20% | -$84.7M | 0.22% | 85 |
|
|
2021
Q1 | $413M | Buy |
6,392,223
+103,300
| +2% | +$6.66M | 0.28% | 68 |
|
|
2020
Q4 | $366M | Buy |
6,288,923
+51,200
| +0.8% | +$3.09M | 0.26% | 70 |
|
|
2020
Q3 | $394M | Buy |
6,237,723
+489,800
| +9% | +$34M | 0.31% | 61 |
|
|
2020
Q2 | $442M | Buy |
5,747,923
+657,100
| +13% | +$50.4M | 0.37% | 54 |
|
|
2020
Q1 | $381M | Buy |
5,090,823
+938,300
| +23% | +$64.8M | 0.4% | 50 |
|
|
2019
Q4 | $270M | Sell |
4,152,523
-203,100
| -5% | -$13.2M | 0.28% | 71 |
|
|
2019
Q3 | $276M | Buy |
4,355,623
+32,199
| +0.7% | +$2.1M | 0.29% | 69 |
|
|
2019
Q2 | $292M | Sell |
4,323,424
-164,200
| -4% | -$10.8M | 0.32% | 60 |
|
|
2019
Q1 | $292M | Buy |
4,487,624
+108,500
| +2% | +$7.21M | 0.32% | 60 |
|
|
2018
Q4 | $274M | Buy |
4,379,124
+60,000
| +1% | +$4.19M | 0.35% | 58 |
|
|
2018
Q3 | $333M | Sell |
4,319,124
-185,300
| -4% | -$14M | 0.37% | 51 |
|
|
2018
Q2 | $319M | Buy |
4,504,424
+141,200
| +3% | +$9.97M | 0.36% | 53 |
|
|
2018
Q1 | $329M | Sell |
4,363,224
-605,800
| -12% | -$48.2M | 0.4% | 47 |
|
|
2017
Q4 | $356M | Buy |
4,969,024
+151,700
| +3% | +$11.5M | 0.38% | 49 |
|
|
2017
Q3 | $390M | Buy |
4,817,324
+41,800
| +0.9% | +$3.2M | 0.44% | 41 |
|
|
2017
Q2 | $338M | Buy |
4,775,524
+107,400
| +2% | +$7.15M | 0.4% | 46 |
|
|
2017
Q1 | $317M | Buy |
4,668,124
+989,400
| +27% | +$69.6M | 0.39% | 44 |
|
|
2016
Q4 | $263M | Sell |
3,678,724
-25,300
| -0.7% | -$1.88M | 0.42% | 41 |
|
|
2016
Q3 | $293M | Sell |
3,704,024
-127,400
| -3% | -$10.3M | 0.47% | 35 |
|
|
2016
Q2 | $320M | Buy |
3,831,424
+87,400
| +2% | +$7.76M | 0.52% | 35 |
|
|
2016
Q1 | $330M | Buy |
3,744,024
+1,076,100
| +40% | +$97M | 0.6% | 29 |
|
|
2015
Q4 | $270M | Buy |
2,667,924
+24,400
| +0.9% | +$2.54M | 0.65% | 23 |
|
|
2015
Q3 | $260M | Buy |
2,643,524
+226,500
| +9% | +$25.2M | 0.67% | 22 |
|
|
2015
Q2 | $283M | Buy |
2,417,024
+105,500
| +5% | +$11.5M | 0.73% | 19 |
|
|
2015
Q1 | $227M | Buy |
2,311,524
+906,000
| +64% | +$92M | 0.61% | 26 |
|
|
2014
Q4 | $132M | Sell |
1,405,524
-67,400
| -5% | -$6.97M | 0.5% | 31 |
|
|
2014
Q3 | $157M | Sell |
1,472,924
-26,400
| -2% | -$2.59M | 0.6% | 22 |
|
|
2014
Q2 | $124M | Buy |
1,499,324
+13,100
| +0.9% | +$1.02M | 0.46% | 35 |
|
|
2014
Q1 | $105M | Sell |
1,486,224
-144,800
| -9% | -$11.4M | 0.41% | 47 |
|
|
2013
Q4 | $123M | Sell |
1,631,024
-20,800
| -1% | -$1.45M | 0.48% | 34 |
|
|
2013
Q3 | $104M | Buy |
1,651,824
+31,700
| +2% | +$1.89M | 0.43% | 44 |
|
|
2013
Q2 | $83M | Buy |
+1,620,124
| New | +$84.4M | 0.36% | 54 |
|
Other funds holding GILD
VCM
VPM
Swiss National Bank's GILD Position: Q1 2026 in Review
Swiss National Bank increased its Gilead Sciences (GILD) stake by 7.1% in Q1 2026, buying an estimated $33.7M and bringing the position to 3,641,000 shares worth $507M. The position accounts for 0.29% of the portfolio, ranked #53.
Swiss National Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Swiss National Bank held 3,641,000 shares of Gilead Sciences worth $507M as of Q1 2026.
- Swiss National Bank bought 240,800 Gilead Sciences shares in Q1 2026, an estimated $33.7M.
- Gilead Sciences made up 0.29% of Swiss National Bank's portfolio in Q1 2026, its #53 holding.
- Swiss National Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.